Full Text:   <1022>

Summary:  <232>

CLC number: S855.9+9

On-line Access: 2017-06-05

Received: 2016-07-12

Revision Accepted: 2016-08-26

Crosschecked: 2017-05-10

Cited: 0

Clicked: 1936

Citations:  Bibtex RefMan EndNote GB/T7714

 ORCID:

Ai-fang Du

http://orcid.org/0000-0002-3796-6621

-   Go to

Article info.
Open peer comments

Journal of Zhejiang University SCIENCE B 2017 Vol.18 No.6 P.453-461

10.1631/jzus.B1600316


Evaluation of potential anti-toxoplasmosis efficiency of combined traditional herbs in a mouse model


Author(s):  Xun-hui Zhuo, Hong-chao Sun, Bin Huang, Hai-jie Yu, Ying Shan, Ai-fang Du

Affiliation(s):  Institute of Preventive Veterinary Medicine & Zhejiang Provincial Key Laboratory of Preventive Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, China; more

Corresponding email(s):   afdu@zju.edu.cn

Key Words:  Toxoplasma gondii, Chinese herbs, Real-time PCR, Survival, Protection


Share this article to: More |Next Article >>>

Xun-hui Zhuo, Hong-chao Sun, Bin Huang, Hai-jie Yu, Ying Shan, Ai-fang Du. Evaluation of potential anti-toxoplasmosis efficiency of combined traditional herbs in a mouse model[J]. Journal of Zhejiang University Science B, 2017, 18(6): 453-461.

@article{title="Evaluation of potential anti-toxoplasmosis efficiency of combined traditional herbs in a mouse model",
author="Xun-hui Zhuo, Hong-chao Sun, Bin Huang, Hai-jie Yu, Ying Shan, Ai-fang Du",
journal="Journal of Zhejiang University Science B",
volume="18",
number="6",
pages="453-461",
year="2017",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1600316"
}

%0 Journal Article
%T Evaluation of potential anti-toxoplasmosis efficiency of combined traditional herbs in a mouse model
%A Xun-hui Zhuo
%A Hong-chao Sun
%A Bin Huang
%A Hai-jie Yu
%A Ying Shan
%A Ai-fang Du
%J Journal of Zhejiang University SCIENCE B
%V 18
%N 6
%P 453-461
%@ 1673-1581
%D 2017
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1600316

TY - JOUR
T1 - Evaluation of potential anti-toxoplasmosis efficiency of combined traditional herbs in a mouse model
A1 - Xun-hui Zhuo
A1 - Hong-chao Sun
A1 - Bin Huang
A1 - Hai-jie Yu
A1 - Ying Shan
A1 - Ai-fang Du
J0 - Journal of Zhejiang University Science B
VL - 18
IS - 6
SP - 453
EP - 461
%@ 1673-1581
Y1 - 2017
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1600316


Abstract: 
Toxoplasma gondii is a worldwide spread protozoan and is able to infect almost all warm-blood animals. No effective drugs are available clinically on toxoplasmosis. Chinese traditional herbal medicines have provided remedies for many health problems. There exists a possibility that chinese herbs may provide protection against T. gondii. This work aims to assess the protective efficacy of combined chinese herbs against T. gondii. We screened five herbal medicines that have different pharmacological effects and combined them into a prescription according to the traditional Chinese medicine compatibility principle. The drug potential and protective efficacy were evaluated through a mouse model by determining the survival time, the parasite load in blood and tissues, the change of cell proportions in blood and histological detection. The results showed that the survival time of mice in the 500 mg chinese herbs group and sulfadiazine group was significantly longer than that of the PBS control group. Also the parasite load in blood and tissues of 500 mg chinese herbs and sulfadiazine groups was significantly lower than that of PBS group at 7 days post infection (dpi), which was in accordance with the result of histological detection. Monocyte and neutrophil of infected mice were remarkably increased while lymphocyte was dramatically decreased compared to that of blank group at 7 dpi. The results demonstrated that the 500 mg dosage of our chinese herbs could slow down the replication of T. gondii and prolong the survival time of mice and could be considered as possible candidate drug against toxoplasmosis.

小鼠模型中研究复方中草药抗弓形虫感染的作用

目的:评估复方中草药对小鼠抗弓形虫的保护力,以期找到新型防治弓形虫病的药物。
创新点:首次在小鼠模型中研究威灵仙、芜荑、白术、刘寄奴和甘草组成的复方中草药的抗弓形虫功效,并发现500 mg的药物能提供较好的保护力。
方法:将ICR雌性小鼠随机分为7组:空白组不攻虫不给药;PBS组攻虫;药物对照组攻虫并口服磺胺嘧啶10 mg/d;实验组攻虫并分别灌胃300、400、500和600 mg/d中药煎剂;攻虫组每只小鼠腹腔注射弓形虫RH株1000个。每日观察各组小鼠死亡情况,在感染后3和7 d采集抗凝血检测血常规,并采集血液、肝、脾和肺组织,提取基因组DNA,通过绝对荧光定量PCR检测各组织样品中的虫荷量,采集感染后7 d的肝、肺和脾组织,制作组织切片,通过H & E染色观察组织病变情况。
结论:试验结果表明,500 mg中药组及磺胺嘧啶药物对照组的小鼠显著地延长了存活时间(图1),且这两组小鼠组织及血液中的虫荷数显著低于其他组(图2),这与小鼠的肝、肺和脾组织病理染色结果一致(图4)。另外,与300、400和600 mg中药处理组相比,500 mg处理组小鼠的单核细胞和淋巴细胞比例均较低(图3),这在一定程度上阻碍了弓形虫在血细胞中的传播。综上所述,500 mg中草药处理组能降低弓形虫的胞内增殖速率,延长小鼠的存活时间,证明该浓度的复方中药具有一定的抗弓形虫效果。

关键词:弓形虫;中草药;荧光定量PCR;存活率

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Reference

[1]Bell, A., Ranford-Cartwright, L., 2002. Real-time quantitative PCR in parasitology. Trends Parasitol., 18(8):338-342.

[2]Cinatl, J., Morgenstern, B., Bauer, G., et al., 2003. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet, 361(9374):2045-2046.

[3]Dadimoghaddam, Y., Daryani, A., Sharif, M., et al., 2014. Tissue tropism and parasite burden of Toxoplasma gondii RH strain in experimentally infected mice. Asian Pac. J. Trop. Med., 7(7):521-524.

[4]Fischer, A.H., Jacobson, K.A., Rose, J., et al., 2008. Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harb. Protoc., 2008(5):pdb.prot4986.

[5]Furtado, J.M., Winthrop, K.L., Butler, N.J., et al., 2013. Ocular toxoplasmosis I: parasitology, epidemiology and public health. Clin. Exp. Ophthalmol., 41(1):82-94.

[6]Innes, E.A., 2010a. A brief history and overview of Toxoplasma gondii. Zoonoses Public Hlth., 57(1):1-7.

[7]Innes, E.A., 2010b. Vaccination against Toxoplasma gondii: an increasing priority for collaborative research? Expert Rev. Vacc., 9(10):1117-1119.

[8]Jongert, E., Roberts, C.W., Gargano, N., et al., 2009. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem. Inst. Oswaldo Cruz., 104(2):252-266.

[9]Kur, J., Holec-Gasior, L., Hiszczynska-Sawicka, E., 2009. Current status of toxoplasmosis vaccine development. Expert Rev. Vaccines, 8(6):791-808.

[10]Lachenmaier, S.M., Deli, M.A., Meissner, M., et al., 2011. Intracellular transport of Toxoplasma gondii through the blood-brain barrier. J. Neuroimmunol., 232(1):119-130.

[11]Li, C., Ying, Q., Su, X., et al., 2012. Development and application of reverse transcription loop-mediated isothermal amplification for detecting live Shewanella putrefaciens in preserved fish sample. J. Food Sci., 77(4): M226-M230.

[12]Machado, A.S., Carneiro, A.C., Bela, S.R., et al., 2014. Biomarker analysis revealed distinct profiles of innate and adaptive immunity in infants with ocular lesions of congenital toxoplasmosis. Mediat. Inflamm., 2014:910621.

[13]Mack, D.G., McLeod, R., 1984. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A. Antimicrob. Agents Chemother., 26(1):26-30.

[14]Mordue, D.G., Sibley, L.D., 2003. A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis. J. Leukoc. Biol., 74(6):1015-1025.

[15]Na-Bangchang, K., Karbwang, J., 2014. Traditional herbal medicine for the control of tropical diseases. Trop. Med. Health, 42(2 Suppl.):S3-S13.

[16]National Pharmacopoeia Committee, 2010. Pharmacopoeia of People Republic of China. Chemical Industry Press, Beijing, China (in Chinese).

[17]Noh, E.M., Lee, Y.R., Hur, H., et al., 2011. Radix clematidis extract inhibits TPA-induced MMP-9 expression by suppressing NF-κB activation in MCF-7 human breast cancer cells. Mol. Med. Rep., 4:879-883.

[18]Petersen, E., Schmidt, D.R., 2003. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? Expert Rev. Anti-infect. Ther., 1(1):175-182.

[19]Qu, D., Han, J., Du, A., 2013. Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re. Exp. Parasitol., 135(2):234-239.

[20]Robben, P.M., LaRegina, M., Kuziel, W.A., et al., 2005. Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis. J. Exp. Med., 201(11):1761-1769.

[21]Romand, S., Chosson, M., Franck, J., et al., 2004. Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am. J. Obstet. Gynecol., 190(3): 797-802.

[22]Shen, G., Wang, X., Sun, H., et al., 2016. Seroprevalence of Toxoplasma gondii infection among HIV/AIDS patients in eastern China. Korean J. Parasitol., 54(1):93-96.

[23]Tan, X., Wang, Y.L., Yang, X.L., et al., 2014. Ethyl acetate extract of Artemisia anomala S. Moore displays potent anti-inflammatory effect. Evid. Based Complement. Alternat. Med., 2014:681352.

[24]Yu, H., Huang, B., Zhuo, X., et al., 2013. Evaluation of a real-time PCR assay based on the single-copy SAG1 gene for the detection of Toxoplasma gondii. Vet. Parasitol., 197(3):670-673.

[25]Zheng, B., Lu, S., Tong, Q., et al., 2013. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice. Vaccine, 31(41):4578-4584.

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - Journal of Zhejiang University-SCIENCE